78 results
Page 4 of 4
6-K
EX-99.1
ti5rktonghsnts469y
22 May 14
Replicel Life Sciences Inc. Form 6-K
12:00am
6-K
EX-99.1
y7nnc
18 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.2
e7u4bgvsq3
18 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.1
p8lrcsu
27 Feb 14
RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress
12:00am
6-K
EX-99.1
pkwzy uhpa4qne4q1
27 Feb 14
Replicel Life Sciences Inc. Form 6-K
12:00am
6-K
EX-99
mkvjjh
9 Jan 14
RepliCel to Commence Trading on the TSX Venture Exchange
12:00am
6-K
9uv5g6m
20 Nov 13
Current report (foreign)
12:00am
6-K
EX-99.1
5qzvh gsmsmq7i5alm
28 Aug 13
Current report (foreign)
12:00am
6-K
EX-99.1
mex53xpje2dxk1
12 Jul 13
Current report (foreign)
12:00am
6-K
EX-99.2
nipcu
12 Jul 13
Current report (foreign)
12:00am
6-K
EX-99
n590x9jk6
6 Jun 13
Replicel and Shiseido Announce Collaboration and Technology Transfer Framework Agreement and Exclusive Geographic Technology License
12:00am
6-K
EX-99
t9d6c
6 Jun 13
Replicel and Shiseido Announce Collaboration and Technology Transfer Framework Agreement and Exclusive Geographic Technology License
12:00am
6-K
zoj856q
29 May 13
Current report (foreign)
12:00am
6-K
jdf4y yqv
1 May 13
Current report (foreign)
12:00am